Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group.
Perwein T, Benesch M, Kandels D, Pietsch T, Schmidt R, Quehenberger F, Bison B, Warmuth-Metz M, Timmermann B, Krauss J, Thomale UW, Kortmann RD, Driever PH, Gnekow AK. Perwein T, et al. Neuro Oncol. 2021 Jul 1;23(7):1148-1162. doi: 10.1093/neuonc/noaa296. Neuro Oncol. 2021. PMID: 33346834 Free PMC article.
Management of children and adolescents with gray zone lymphoma: A case series.
Perwein T, Lackner H, Ebetsberger-Dachs G, Beham-Schmid C, Zach K, Tamesberger M, Simonitsch-Klupp I, Lüftinger R, Dworzak M, Mann G, Benesch M, Attarbaschi A; Austrian Society of Pediatric Hematology and Oncology and the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Perwein T, et al. Pediatr Blood Cancer. 2020 May;67(5):e28206. doi: 10.1002/pbc.28206. Epub 2020 Feb 9. Pediatr Blood Cancer. 2020. PMID: 32037692
Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors.
Baugh JN, Gielen GH, van Vuurden DG, Veldhuijzen van Zanten SEM, Hargrave D, Massimino M, Biassoni V, Morales la Madrid A, Karremann M, Wiese M, Thomale U, Janssens GO, von Bueren AO, Perwein T, Hoving EW, Pietsch T, Andreiuolo F, Kramm CM. Baugh JN, et al. Among authors: perwein t. Neurooncol Adv. 2021 Aug 18;3(1):vdab113. doi: 10.1093/noajnl/vdab113. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34595479 Free PMC article.
Immunological recovery following HLA-matched CD3+ TCR αß+/CD19+ depleted hematopoietic stem cell transplantation in children.
Sperl D, Lang P, Benesch M, Bainschab A, Urban C, Wilfing R, Feuchtinger T, Döring M, Seitz C, Strenger V, Lackner H, Seidel MG, Perwein T, Handgretinger R, Sipurzynski S, Rosskopf K, Schwinger W. Sperl D, et al. Among authors: perwein t. Pediatr Transplant. 2022 Aug;26(5):e14285. doi: 10.1111/petr.14285. Epub 2022 Apr 19. Pediatr Transplant. 2022. PMID: 35441401
Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.
Gielen GH, Baugh JN, van Vuurden DG, Veldhuijzen van Zanten SEM, Hargrave D, Massimino M, Biassoni V, Morales la Madrid A, Karremann M, Wiese M, Thomale U, Janssens GO, von Bueren AO, Perwein T, Nussbaumer G, Hoving EW, Niehusmann P, Gessi M, Kwiecien R, Bailey S, Pietsch T, Andreiuolo F, Kramm CM. Gielen GH, et al. Among authors: perwein t. Neurooncol Adv. 2022 May 20;4(1):vdac077. doi: 10.1093/noajnl/vdac077. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35733513 Free PMC article.
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.
Benesch M, Perwein T, Apfaltrer G, Langer T, Neumann A, Brecht IB, Schuhmann MU, Cario H, Frühwald MC, Vollert K, van Buiren M, Deng MY, Seitz A, Haberler C, Mynarek M, Kramm C, Sahm F, Robe PA, Dankbaar JW, Hoff KV, Warmuth-Metz M, Bison B. Benesch M, et al. Among authors: perwein t. AJNR Am J Neuroradiol. 2022 Oct;43(10):1523-1529. doi: 10.3174/ajnr.A7647. Epub 2022 Sep 22. AJNR Am J Neuroradiol. 2022. PMID: 36137663 Free PMC article.
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Peyrl A, Chocholous M, Sabel M, Lassaletta A, Sterba J, Leblond P, Nysom K, Torsvik I, Chi SN, Perwein T, Jones N, Holm S, Nyman P, Mörse H, Öberg A, Weiler-Wichtl L, Leiss U, Haberler C, Schmook MT, Mayr L, Dieckmann K, Kool M, Gojo J, Azizi AA, André N, Kieran M, Slavc I. Peyrl A, et al. Among authors: perwein t. JAMA Oncol. 2023 Dec 1;9(12):1688-1695. doi: 10.1001/jamaoncol.2023.4437. JAMA Oncol. 2023. PMID: 37883081 Free PMC article. Clinical Trial.
17 results